查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1623659

基因分型檢測市場評估:按產品、技術、應用、最終用戶和地區劃分的機會和預測（2018-2032 年）

Genotyping Assay Market Assessment, By Products, By Technology, By Application By End-user, By Region, Opportunities and Forecast, 2018-2032F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 232 Pages | 商品交期: 3-5個工作天內

價格

全球基因分型檢測市場規模預計將從 2024 年的 209.9 億美元增長到 2032 年的 635.4 億美元，預測期內的複合年增長率為 14.85%。

由於遺傳疾病和慢性病發病率的上升以及基因組技術的進步，預計基因分型檢測的市場需求將在未來幾年呈指數級增長。

基因分型分析是實驗室透過分析 DNA 來確定身體基因組成（基因型）的一種方法。在基因組的特定位置可以識別出遺傳變異，例如單一核甘酸多重單核甘酸多態性 (SNP)、插入、缺失和其他突變。由於遺傳疾病的盛行率不斷上升、精準醫療以及個人化醫療解決方案的需求不斷增長，基因分析市場正在經歷顯著增長。下一代微晶片測序（NGS）、聚合酶鍊式反應（PCR）以及準確有效的基因分析等先進技術的廣泛應用推動了市場的發展。

主要參與者正專注於產品創新、策略合作以及藥物基因組學、腫瘤學和傳染病診斷等領域的應用擴展，以推動市場成長。

本報告調查了全球基因分型檢測市場，並提供了市場定義和概述、市場規模趨勢和預測、各個細分市場、地區和主要國家的詳細分析、行業結構、影響市場增長的因素分析、案例研究、競爭格局和主要公司的概況。

目錄

第 1 章 專案範圍與定義

第 2 章 研究方法

第 3 章執行摘要

第 4 章全球基因分型檢測市場展望

  • 市場規模分析及預測
  • 市佔率分析及預測
    • 按產品
    • 按技術
    • 依用途
    • 按最終用戶
    • 按地區
    • 公司佔有率分析（前 5 名及其他）
  • 市場地圖分析

第 5 章北美基因分型檢測市場展望

  • 市場規模分析及預測
  • 市佔率分析及預測
  • 國家市場評估
    • 美國
    • 加拿大
    • 墨西哥

第6章 歐洲基因分型檢測市場展望

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙 火雞
  • 波蘭

第7章亞太地區基因分型檢測市場展望

  • 印度
  • 中國
  • 日本
  • 澳大利亞 越南
  • 韓國
  • 印尼
  • 菲律賓

第 8 章南美洲基因分型檢測市場展望

  • 巴西
  • 阿根廷

第 9 章：中東與非洲基因分型檢測市場展望

  • 沙烏地阿拉伯
  • 阿聯酋
  • 南非

第 10 章 供需分析

第 11 章 價值鏈分析

第 12 章 波特五力分析

第 13 章 PESTLE 分析

第 14 章 定價分析

第 15 章 市場動態

  • 市場推動因素
  • 市場課題

第 16 章 市場趨勢與發展

第 17 章 監理架構與創新

  • 臨床試驗
  • 監理機關核准

第 18 章：專利格局

第 19 章案例研究

第 20 章 競爭格局

  • 前 5 個競爭矩陣
  • 前 5 家公司的 SWOT 分析
  • 前 8 家公司的狀況
      賽默飛世爾科技公司 Eurofins Scientific Inc.
    • F. 霍夫曼-拉羅氏公司 Bio-Rad 實驗室公司 GE醫療集團 Illumina 公司 QIAGEN N.V. 丹納赫公司

第 21 章 策略建議

第22章 關於我們/免責聲明

Product Code: MX12497

Global genotyping assay market is projected to witness a CAGR of 14.85% during the forecast period 2025-2032, growing from USD 20.99 billion in 2024 to USD 63.54 billion in 2032. The market demand for genotyping assays is anticipated to thrive drastically in the forecast years due to the rising prevalence of genetic disorders, chronic diseases, and technological advancements in genomic technologies.

Genotyping analysis is a method used in the laboratory to determine the body's genetic composition (genetic type) by analyzing the DNA. In a specific place of the genome, genetic mutations are identified, such as individual nucleotide multiple type single nucleotide polymorphisms (SNPs), insertions, deletions, or other mutations. The genetic analysis market grows significantly due to an increase in the rate of genetic disorders, the accurate medical field, and the growing demand for personalized healthcare solutions. The market is promoted by the extensive introduction of advanced technology, such as the next-generation microchip sequence (NGS), the polymerase chain reaction (PCR), and the analysis of accurate and effective genetic analysis. Leading companies are focusing on product innovation, strategic alliances, and application expansion in areas such as pharmacogenomics, oncology, infectious disease diagnostics, etc., driving the market growth. For instance, in October 2024, LGC Biosearch Technologies Limited launched Amp-Seq One, a revolutionary one-step amplicon sequencing workflow for commercial breeding. With a 120-minute turnaround time and no liquid handling equipment needed, it minimizes hands-on time, reduces consumables, lowers contamination risks, doubles throughput, and delivers unmatched speed and precision in agricultural genomics.

Increasing Prevalence of Genetic Disorders

The growing incidence of genetic diseases is a significant growth factor for the global genotyping assay market. Increasing cases of cancer, cystic fibrosis, sickle cell anemia, and cardiovascular diseases necessitate early and accurate diagnostic tools. Genotyping assays can accurately identify the genetic mutations to allow early intervention and targeted therapy. There is now increased awareness about hereditary and somatic mutations, further increasing demand for genotyping in clinical as well as research areas. Awareness about genetic testing is also increased by both healthcare providers and patients with the implementation of genetic diagnostics in routine medical care, the adoption of genotyping assays market growth in the forecast period. For instance, in October 2024, Revvity, Inc. announced the launch of the in-vitro diagnostic EURORealTime APOE assay in CE-marked European countries. This assay enables precise apolipoprotein E (APOE) gene genotyping to assess Alzheimer's patients' risk for adverse side effects from anti-amyloid therapies, which is crucial for personalized treatment plans and managing potential amyloid-related imaging abnormalities-related risks.

Advancements in Genotyping Technologies

Advancement in genotyping technologies is poised to witness significant growth in the genotyping market; the increasing prevalence of genetic disorders is fueling the demand for accurate and efficient genotyping methods, particularly in the field of personalized medicine and drug development. Advanced technologies such as next-generation sequencing and polymerase revolutionized genetic analysis that guarantees quick and accurate detection of genetic fluctuations in various uses. These technological innovations enhance the effectiveness of genotyping analysis, reduce costs, and make it more affordable for researchers and medical workers. Additionally, increasing collaborations between academic institutions and biotech companies are helping to create an environment conducive to innovation, thereby expanding market growth. For instance, in June 2024, MGI Tech Co., Ltd. announced a new automated workflow for large-scale Low-pass Whole Genome Sequencing (WGS) Solutions for Agriculture. The solution streamlines molecular breeding with tools for extraction, library prep, sequencing, and SNP/InDel calling. The MGIEasy Large-scale polymerase chain reaction Free FS Library Prep Set simplifies library construction with a plate-based design, cutting steps, time, and consumables.

Reagents and Kits Segment to Dominate the Genotyping Assay Market

The reagents and kits segment is anticipated to dominate the genotyping assay market primarily because of its role in ensuring accurate results, as well as reproducible results, across various genotyping applications. The segment further benefits from the increasing adoption of ready-to-use kits, which simplify the workflow and reduce procedural errors in research and clinical settings. Due to the increasing demand for high-throughput genotyping, innovations in reagent formulation for technologies like next-generation sequencing and polymerase chain reaction and microarrays enhance the segment's growth prospects. Additionally, this contributes to a continuous flow of revenue, making the segment fuel the market growth. For instance, in June 2024, Omixon Inc. launched HoloGRAFT ONE, a simplified digital polymerase chain reaction kit for monitoring donor-derived cell-free DNA (dd-cfDNA) in transplant research. Its single-use, dry reagent format eliminates handling errors and streamlines workflows. The assay offers direct, absolute quantification of donor-specific genetic markers for improved transplant monitoring.

North America Dominates Genotyping Assay Market

The overall market for genotyping assays worldwide is dominated by North America, due to the excellent infrastructural facilities for healthcare available here, high research and development activity, and extensive adoption of advanced genomic technologies. Notable biotechnology and pharmaceutical firms, as well as huge government spending on genomics research, make further enhancements in the market. The increasing incidence of chronic diseases, personalized medicine initiatives, and the increasing demand for precision diagnostics have created a strong demand for genotyping assays in the region. For instance, in May 2024, F. Hoffmann-La Roche AG launched an HPV self-collection solution that received FDA approval, offering an accessible screening option. Individuals can collect vaginal samples in a healthcare setting, then analyze them using Roche's Cobas molecular instrument. Positive results lead to further care with a healthcare provider, enabling early detection of cervical cancer risks.

Future Market Scenario (2025-2032F)

The future market scenario for the global genotyping assay market looks very promising, as rapid advancement in genomic technologies and the adoption of precision medicine are driving this market. Emerging trends such as artificial intelligence and machine learning integration in genomic data analysis are expected to streamline workflows and enhance diagnostic accuracy. The increasing incidence of genetic diseases, along with the increased demand for pharmacogenomics and personalized medicines, will fuel further growth in the market. In addition, the increased focus on agricultural genomics and animal breeding is expected to create new growth opportunities. Increased access to cost-effective, high-throughput genotyping platforms is sustainable growth in the market. For instance, in March 2024, Nucleus Genomics, Inc. launched DNA analysis and whole genome sequencing services for personalized genetic risk and health reports. Customers can upload existing microarray DNA data to gain insights into diseases like type 2 diabetes and breast cancer, with analysis incorporating lifestyle factors like age, body mass index, and cholesterol.

Key Players Landscape and Outlook

The genotyping assay market is characterized by its dynamic landscape, shaped by the actions of numerous key players, including significant business agreements and regulatory approvals for various products. The sector experienced a surge in strategic initiatives, encompassing mergers, acquisitions, and collaborations, reflecting a robust drive for innovation and growth within the industry.

For instance, in January 2024, Thermo Fisher Scientific Inc. launched Axiom PangenomiX Array, its most comprehensive and ethnically diverse array of genetic research. Designed for large-scale disease studies and pharmacogenomic research, this array offers optimal genetic coverage based on the pangenome, a more inclusive representation of human genomic variation. This launch supports the shift toward proactive healthcare and personalized medicine, focusing on the genetic basis of disease risk and drug responses.

For instance, in September 2024, Integrated DNA Technologies, Inc. launched Archer HRD Technology for comprehensive genomic profiling solutions with the addition of homologous recombination deficiency assessment. This new technology is available as a standalone assay, a supplementary module, or integrated into Archer's existing NGS panels, offering customizable solutions for cancer research labs.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Genotyping Assay Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Instruments
      • 4.2.1.2. Software and Services
      • 4.2.1.3. Reagents and Kits
    • 4.2.2. By Technology
      • 4.2.2.1. Polymerase Chain Reaction
      • 4.2.2.2. Capillary Electrophoresis
      • 4.2.2.3. Sequencing
      • 4.2.2.4. Microarrays
      • 4.2.2.5. Mass Spectrometry
      • 4.2.2.6. Others
    • 4.2.3. By Application
      • 4.2.3.1. Pharmacogenomics
      • 4.2.3.2. Agriculture Biotechnology
      • 4.2.3.3. Animal Genetics
      • 4.2.3.4. Diagnostics and Personalized Medicine
      • 4.2.3.5. Others
    • 4.2.4. By End-user
      • 4.2.4.1. Pharmaceutical and Biopharmaceutical Companies
      • 4.2.4.2. Diagnostics and Research Laboratories
      • 4.2.4.3. Academics Institutes
      • 4.2.4.4. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Product
    • 4.3.2. By Technology
    • 4.3.3. By Application
    • 4.3.4. By End-user
    • 4.3.5. By Region

5. North America Genotyping Assay Market Outlook, 2018-2032F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Instruments
      • 5.2.1.2. Software and Services
      • 5.2.1.3. Reagents and Kits
    • 5.2.2. By Technology
      • 5.2.2.1. Polymerase Chain Reaction
      • 5.2.2.2. Capillary Electrophoresis
      • 5.2.2.3. Sequencing
      • 5.2.2.4. Microarrays
      • 5.2.2.5. Mass Spectrometry
      • 5.2.2.6. Others
    • 5.2.3. By Application
      • 5.2.3.1. Pharmacogenomics
      • 5.2.3.2. Agriculture Biotechnology
      • 5.2.3.3. Animal Genetics
      • 5.2.3.4. Diagnostics and Personalized Medicine
      • 5.2.3.5. Others
    • 5.2.4. By End-user
      • 5.2.4.1. Pharmaceutical and Biopharmaceutical Companies
      • 5.2.4.2. Diagnostics and Research Laboratories
      • 5.2.4.3. Academics Institutes
      • 5.2.4.4. Others
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Genotyping Assay Market Outlook, 2018-2032F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product
          • 5.3.1.2.1.1. Instruments
          • 5.3.1.2.1.2. Software and Services
          • 5.3.1.2.1.3. Reagents and Kits
        • 5.3.1.2.2. By Technology
          • 5.3.1.2.2.1. Polymerase Chain Reaction
          • 5.3.1.2.2.2. Capillary Electrophoresis
          • 5.3.1.2.2.3. Sequencing
          • 5.3.1.2.2.4. Microarrays
          • 5.3.1.2.2.5. Mass Spectrometry
          • 5.3.1.2.2.6. Others
        • 5.3.1.2.3. By Application
          • 5.3.1.2.3.1. Pharmacogenomics
          • 5.3.1.2.3.2. Agriculture Biotechnology
          • 5.3.1.2.3.3. Animal Genetics
          • 5.3.1.2.3.4. Diagnostics and Personalized Medicine
          • 5.3.1.2.3.5. Others
        • 5.3.1.2.4. By End-user
          • 5.3.1.2.4.1. Pharmaceutical and Biopharmaceutical Companies
          • 5.3.1.2.4.2. Diagnostics and Research Laboratories
          • 5.3.1.2.4.3. Academics Institutes
          • 5.3.1.2.4.4. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Genotyping Assay Market Outlook, 2018-2032F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Genotyping Assay Market Outlook, 2018-2032F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Genotyping Assay Market Outlook, 2018-2032F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Genotyping Assay Market Outlook, 2018-2032F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

  • 17.1. Regulatory Approvals
  • 17.2. Clinical Trials

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 8 Market Players
    • 20.3.1. Thermo Fisher Scientific Inc.
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 20.3.2. Eurofins Scientific Inc.
    • 20.3.3. F. Hoffmann-La Roche AG
    • 20.3.4. Bio-Rad Laboratories Inc.
    • 20.3.5. GE Healthcare Inc.
    • 20.3.6. Illumina Inc.
    • 20.3.7. QIAGEN N.V.
    • 20.3.8. Danaher Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 3. Global Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 4. Global Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 5. Global Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 6. Global Genotyping Assay Market Share (%), By Region, 2018-2032F
  • Figure 7. North America Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 8. North America Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 9. North America Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 10. North America Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 11. North America Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 12. North America Genotyping Assay Market Share (%), By Country, 2018-2032F
  • Figure 13. United States Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 14. United States Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 15. United States Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 16. United States Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 17. United States Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 18. Canada Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 19. Canada Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 20. Canada Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 21. Canada Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 22. Canada Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 23. Mexico Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Mexico Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 25. Mexico Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 26. Mexico Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 27. Mexico Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 28. Europe Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Europe Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 30. Europe Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 31. Europe Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 32. Europe Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 33. Europe Genotyping Assay Market Share (%), By Country, 2018-2032F
  • Figure 34. Germany Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 35. Germany Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 36. Germany Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 37. Germany Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 38. Germany Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 39. France Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 40. France Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 41. France Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 42. France Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 43. France Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 44. Italy Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Italy Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 46. Italy Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 47. Italy Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 48. Italy Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 49. United Kingdom Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 50. United Kingdom Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 51. United Kingdom Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 52. United Kingdom Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 53. United Kingdom Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 54. Russia Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 55. Russia Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 56. Russia Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 57. Russia Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 58. Russia Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 59. Netherlands Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 60. Netherlands Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 61. Netherlands Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 62. Netherlands Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 63. Netherlands Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 64. Spain Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. Spain Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 66. Spain Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 67. Spain Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 68. Spain Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 69. Turkey Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Turkey Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 71. Turkey Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 72. Turkey Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 73. Turkey Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 74. Poland Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 75. Poland Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 76. Poland Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 77. Poland Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 78. Poland Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 79. South America Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 80. South America Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 81. South America Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 82. South America Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 83. South America Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 84. South America Genotyping Assay Market Share (%), By Country, 2018-2032F
  • Figure 85. Brazil Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 86. Brazil Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 87. Brazil Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 88. Brazil Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 89. Brazil Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 90. Argentina Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Argentina Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 92. Argentina Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 93. Argentina Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 94. Argentina Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 95. Asia-Pacific Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 96. Asia-Pacific Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 97. Asia-Pacific Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 98. Asia-Pacific Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 99. Asia-Pacific Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 100. Asia-Pacific Genotyping Assay Market Share (%), By Country, 2018-2032F
  • Figure 101. India Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 102. India Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 103. India Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 104. India Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 105. India Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 106. China Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. China Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 108. China Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 109. China Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 110. China Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 111. Japan Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 112. Japan Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 113. Japan Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 114. Japan Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 115. Japan Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 116. Australia Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 117. Australia Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 118. Australia Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 119. Australia Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 120. Australia Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 121. Vietnam Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 122. Vietnam Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 123. Vietnam Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 124. Vietnam Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 125. Vietnam Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 126. South Korea Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 127. South Korea Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 128. South Korea Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 129. South Korea Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 130. South Korea Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 131. Indonesia Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 132. Indonesia Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 133. Indonesia Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 134. Indonesia Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 135. Indonesia Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 136. Philippines Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 137. Philippines Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 138. Philippines Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 139. Philippines Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 140. Philippines Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 141. Middle East & Africa Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 142. Middle East & Africa Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 143. Middle East & Africa Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 144. Middle East & Africa Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 145. Middle East & Africa Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 146. Middle East & Africa Genotyping Assay Market Share (%), By Country, 2018-2032F
  • Figure 147. Saudi Arabia Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 148. Saudi Arabia Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 149. Saudi Arabia Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 150. Saudi Arabia Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 151. Saudi Arabia Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 152. UAE Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 153. UAE Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 154. UAE Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 155. UAE Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 156. UAE Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 157. South Africa Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 158. South Africa Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 159. South Africa Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 160. South Africa Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 161. South Africa Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 162. By Products Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 163. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024